Pfizer's Global R&D Network: Rapid Integration Means Doing More With Less
Executive Summary
Pfizer's new R&D site structure will establish East and West Coast innovation corridors in the U.S., a large, centralized Europe-based R&D hub in Sandwich, U.K., and a network of nine specialized laboratories around the world
You may also be interested in...
Pfizer's Message To Wall Street: We're Doing Things Differently Now
Three months after closing Pfizer's $68 billion acquisition of Wyeth (1"The Pink Sheet" DAILY, Jan. 26, 2009), Pfizer has already integrated both companies' R&D organizations and is now working to achieve steady, predictable, but diversified growth, CEO Jeff Kindler said at a Goldman Sachs health care conference Jan. 6
Pfizer Selects Sites for its Post-Merger Global R&D Network
Newly merged company will cut R&D staff by 15 percent, though timing is unclear.
Pfizer’s New Org Chart Brings Eight Wyeth Execs Topside
In a move designed to allay concerns about post-Wyeth integration challenges, Pfizer outlined on April 7 the leadership structure of the future entity